Molecular Diagnostic Tests

OPTI Medical Systems · Z6.H41


The OPTI SARS-CoV-2 RT-PCR Test is based on real-time reverse transcription polymerase chain reaction (RT-PCR), which provides detection of the viral RNA in the sample. The test can be used on both individual samples as well as in pools of 5 samples for screening purposes. It is designed for the detection of SARS-CoV-2 RNA extracted from nasopharyngeal swabs, oropharyngeal swabs and other upper respiratory sample types, collected from any individual, including from individuals without symptoms or other reasons to suspect COVID-19 infection. The test detects new SARS-CoV-2 variants of concern (UK B.1.1.7, Brazil P.1, South Africa B.1.351, and Delta B.1.617.2) based on the sequences submitted to the GISAID database.

Access the event

See all the content and easy-to-use features by logging in or registering!